Genome sharing

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The 23Andme, Inc. patent solves the following problem:

Recently, interest in genetics and genetic testing raised as to increase the amount of research on how genetic information of a human influence on a person's background, appearance, behavior, and physiology. Genetic information may be available to a person through the Internet. To prevent others from seeing the personal data, the individual is often required to login using a password to gain access to his data. In some cases, a person may want to share his personal information with one or more other people, such as family members. However, current techniques for sharing personal data on basic and had limited capabilities. Thus, growth in the share of personal data that can be useful.

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 9336177 B2 deals with Genome sharing.
Sharing the data revealed. In some cases, the sharing of data includes receiving a request to share information from a first account to a second account, receiving an indication of a plurality of first profile account associated with the first account to share with the second account, and build share from the plurality of first account profile in the second account, which divide up the second account with read access to a subset of nonpublic data associated with the plurality of first profile accounts.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Processing data from genotyping chips

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The 23Andme, Inc. patent solves the following problem:

The instructions for making cells in the human body is encoded in deoxyribonucleic acid (DNA). DNA is a long, ladder-shaped molecule, each equivalent to climb up on a pair of interlocking units, called bases, appointed by the four letters of DNA AlphaBeta, T, G and C. a always pairs or chains with T, and G always pairs or chains with C. the order of these four letters in one DNA called human genome.

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 9218451 B2 deals with Processing data from genotyping chips.
Processing genetic data includes receiving two or more sets of genetic data for an individual from one or more genetic source of data, where the genetic data set contains the data of deoxyribonucleic acid individuals (DNA); combining the genetic data sets from one or more genetic data sources to obtain a set of merged genetic data for each, including: identifying genetic data sets of data contradictory, acknowledged that data corresponding to a genetic marker associated with a difference that takes place in a region of the human genome; analyzing the identified data to resolve a dispute dedicated to recognizing conflicting data and automatically determine a proper value corresponding to the genetic mark, the analysis and the determination based at least part of the contextual information; and gather the appropriate value of the set of merged genetic data.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Identification of matrilineal or patrilineal relatives

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The 23Andme, Inc. patent solves the following problem:

Genealogy is the study of family history and lineage of ancestors. It is an interesting subject to study many professionals as well as hobbyists. Traditional techniques genealogical study often includes building family trees based on surnames and historical records. As gene sequencing technology becomes more accessible, there is growing interest in genetic ancestry testing in recent years.

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 9116882 B1 deals with Identification of matrilineal or patrilineal relatives.
Determine relative relationships among a mass of people, namely: access to user-specified genealogical information at least some of the plurality of individuals and genetic information recombinable deoxyribonucleic acid (DNAs ) at least some of the plurality of individuals; determining, using one or more computer processors and among the mass of people, one or more related people relative to a target individual, and information concerning one or more more related individuals, and present information about at least one of the one or more related individuals, including the presentation of a sign in if at least one of one or more related to individuals is a matrilineal relative or a patrilineal relative to each target.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Polymorphisms associated with Parkinson’s disease

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The 23Andme, Inc. patent solves the following problem:

Parkinson's disease (PD) is a progressive degenerative disease of the central nervous system (CNS). PD is characterized by muscle rigidity, tremor, a slow physical movement (bradykinesia), impaired balance and coordination, and, in advanced stages, a loss of physical movement (akinesia). Over one million Americans suffer from Parkinson's disease, with prevalence of approximately 1 in 272 or 0.37% in the United States (US Census Bureau, Population Estimates, 2004).

Our analysis of this patent is as follows:

23Andme, Inc.’s patent US 8187811 B2 deals with Polymorphisms associated with Parkinson’s disease.
invention provides human polymorphisms associated with Parkinson's disease (PD). Also disclosed are compositions and methods for use in diagnostics, prognostics, prevention, treatment and / or study in PD.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.